Mary‑Dell Chilton, the NC biochemist who helped create the first genetically modified plants, died at 87 in Carrboro. Her work underpins modern crop biotechnology.

The 101st Airborne tested massed, low‑cost "attritable" drones at JRTC — roughly 150 of 228 attack airframes were 3D‑printed by soldiers, leaders say.

APS, SRP and TEP have launched a six‑month siting study to identify potential nuclear reactor locations across Arizona as demand surges.

Visa filings show Anthropic listing base salaries above $1M for a few technical roles, highlighting how hot the AI hiring wars have become in San Francisco.

IU Health opened an FDA-cleared 3D print studio at Methodist Hospital, producing patient-specific anatomical models for surgical planning and training.

Airwallex raised $320M at an $11B valuation as it rolls out AI products that aim to automate finance and launch an agentic consumer wallet.

A San Francisco judge refused to toss a major class action accusing Workday’s AI hiring tools of discriminating by race, age and disability. The decision keeps key claims alive.

Attorneys say more than 160 Florida suits claim website chatbots recorded users without consent, raising steep statutory‑damages risk for companies that use web chat tools.

The New York Times amended its June 25 complaint, dropping a claim against OpenAI and refocusing its allegations on Microsoft in a major copyright battle.

A $3.07M TSIF grant will back Quantum Global's new Austin services hub, promising 287 jobs and more than $43M in investment.

Apple raised prices on Macs and iPads as AI-driven memory and storage costs surged, pushing some popular entry-level models up by hundreds of dollars. The company says it can no longer absorb soaring component bills.

Duke and other labs are testing drugs and mitochondrial therapies that could ease chronic pain without sparking opioid addiction.

Remix Therapeutics has agreed to a reverse merger with Passage Bio and lined up an oversubscribed $100M private placement to fund REM‑422 into pivotal readouts.